As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
Articles on Sovaldi
Displaying all articles
Developing brand new treatments and cures isn’t the only way to achieve a major reduction in cancer deaths worldwide.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…
Top contributors
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Richard Doll Professor of Epidemiology and Medicine, University of Oxford
-
Health Services Researcher, The University of Melbourne
-
Professor of Public Policy, University of Southern California